Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
The global market for Ophthalmic Anti-infective Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Ophthalmic Anti-infective Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Ophthalmic Anti-infective Drug players cover Alcon, AbbVie, Bausch Health, Santen Pharmaceutical and Lupin Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Ophthalmic Anti-infective Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Ophthalmic Anti-infective Drug market, with both quantitative and qualitative data, to help readers understand how the Ophthalmic Anti-infective Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Ophthalmic Anti-infective Drug market and forecasts the market size by Type (Eyedrops, Gels and Ointments), by Application (Hospital, Retail Pharmacy and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Eyedrops
Gels
Ointments
Other
Segmentation by application
Hospital
Retail Pharmacy
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Chapter Introduction
Chapter 1: Scope of Ophthalmic Anti-infective Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Ophthalmic Anti-infective Drug market size and CAGR, Ophthalmic Anti-infective Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Ophthalmic Anti-infective Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Ophthalmic Anti-infective Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Ophthalmic Anti-infective Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Alcon, AbbVie, Bausch Health, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex, Akorn, Johnson & Johnson and Thea pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Anti-infective Drug Market Size 2017-2028
2.1.2 Ophthalmic Anti-infective Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Ophthalmic Anti-infective Drug Segment by Type
2.2.1 Eyedrops
2.2.2 Gels
2.2.3 Ointments
2.2.4 Other
2.3 Ophthalmic Anti-infective Drug Market Size by Type
2.3.1 Ophthalmic Anti-infective Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
2.4 Ophthalmic Anti-infective Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Ophthalmic Anti-infective Drug Market Size by Application
2.5.1 Ophthalmic Anti-infective Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
3 Ophthalmic Anti-infective Drug Market Size by Player
3.1 Ophthalmic Anti-infective Drug Market Size Market Share by Players
3.1.1 Global Ophthalmic Anti-infective Drug Revenue by Players (2020-2022)
3.1.2 Global Ophthalmic Anti-infective Drug Revenue Market Share by Players (2020-2022)
3.2 Global Ophthalmic Anti-infective Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ophthalmic Anti-infective Drug by Regions
4.1 Ophthalmic Anti-infective Drug Market Size by Regions (2017-2022)
4.2 Americas Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
4.3 APAC Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
4.4 Europe Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Ophthalmic Anti-infective Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Ophthalmic Anti-infective Drug Market Size by Country (2017-2022)
5.2 Americas Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
5.3 Americas Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Anti-infective Drug Market Size by Region (2017-2022)
6.2 APAC Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
6.3 APAC Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ophthalmic Anti-infective Drug by Country (2017-2022)
7.2 Europe Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
7.3 Europe Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Anti-infective Drug by Region (2017-2022)
8.2 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ophthalmic Anti-infective Drug Market Forecast
10.1 Global Ophthalmic Anti-infective Drug Forecast by Regions (2023-2028)
10.1.1 Global Ophthalmic Anti-infective Drug Forecast by Regions (2023-2028)
10.1.2 Americas Ophthalmic Anti-infective Drug Forecast
10.1.3 APAC Ophthalmic Anti-infective Drug Forecast
10.1.4 Europe Ophthalmic Anti-infective Drug Forecast
10.1.5 Middle East & Africa Ophthalmic Anti-infective Drug Forecast
10.2 Americas Ophthalmic Anti-infective Drug Forecast by Country (2023-2028)
10.2.1 United States Ophthalmic Anti-infective Drug Market Forecast
10.2.2 Canada Ophthalmic Anti-infective Drug Market Forecast
10.2.3 Mexico Ophthalmic Anti-infective Drug Market Forecast
10.2.4 Brazil Ophthalmic Anti-infective Drug Market Forecast
10.3 APAC Ophthalmic Anti-infective Drug Forecast by Region (2023-2028)
10.3.1 China Ophthalmic Anti-infective Drug Market Forecast
10.3.2 Japan Ophthalmic Anti-infective Drug Market Forecast
10.3.3 Korea Ophthalmic Anti-infective Drug Market Forecast
10.3.4 Southeast Asia Ophthalmic Anti-infective Drug Market Forecast
10.3.5 India Ophthalmic Anti-infective Drug Market Forecast
10.3.6 Australia Ophthalmic Anti-infective Drug Market Forecast
10.4 Europe Ophthalmic Anti-infective Drug Forecast by Country (2023-2028)
10.4.1 Germany Ophthalmic Anti-infective Drug Market Forecast
10.4.2 France Ophthalmic Anti-infective Drug Market Forecast
10.4.3 UK Ophthalmic Anti-infective Drug Market Forecast
10.4.4 Italy Ophthalmic Anti-infective Drug Market Forecast
10.4.5 Russia Ophthalmic Anti-infective Drug Market Forecast
10.5 Middle East & Africa Ophthalmic Anti-infective Drug Forecast by Region (2023-2028)
10.5.1 Egypt Ophthalmic Anti-infective Drug Market Forecast
10.5.2 South Africa Ophthalmic Anti-infective Drug Market Forecast
10.5.3 Israel Ophthalmic Anti-infective Drug Market Forecast
10.5.4 Turkey Ophthalmic Anti-infective Drug Market Forecast
10.5.5 GCC Countries Ophthalmic Anti-infective Drug Market Forecast
10.6 Global Ophthalmic Anti-infective Drug Forecast by Type (2023-2028)
10.7 Global Ophthalmic Anti-infective Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Alcon
11.1.1 Alcon Company Information
11.1.2 Alcon Ophthalmic Anti-infective Drug Product Offered
11.1.3 Alcon Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Alcon Main Business Overview
11.1.5 Alcon Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Ophthalmic Anti-infective Drug Product Offered
11.2.3 AbbVie Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Ophthalmic Anti-infective Drug Product Offered
11.3.3 Bausch Health Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Company Information
11.4.2 Santen Pharmaceutical Ophthalmic Anti-infective Drug Product Offered
11.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Santen Pharmaceutical Main Business Overview
11.4.5 Santen Pharmaceutical Latest Developments
11.5 Lupin Pharmaceuticals
11.5.1 Lupin Pharmaceuticals Company Information
11.5.2 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
11.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Lupin Pharmaceuticals Main Business Overview
11.5.5 Lupin Pharmaceuticals Latest Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Ophthalmic Anti-infective Drug Product Offered
11.6.3 Apotex Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Apotex Main Business Overview
11.6.5 Apotex Latest Developments
11.7 Akorn
11.7.1 Akorn Company Information
11.7.2 Akorn Ophthalmic Anti-infective Drug Product Offered
11.7.3 Akorn Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Akorn Main Business Overview
11.7.5 Akorn Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Ophthalmic Anti-infective Drug Product Offered
11.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Thea pharmaceuticals
11.9.1 Thea pharmaceuticals Company Information
11.9.2 Thea pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
11.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Thea pharmaceuticals Main Business Overview
11.9.5 Thea pharmaceuticals Latest Developments
11.10 URSAPHARM
11.10.1 URSAPHARM Company Information
11.10.2 URSAPHARM Ophthalmic Anti-infective Drug Product Offered
11.10.3 URSAPHARM Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 URSAPHARM Main Business Overview
11.10.5 URSAPHARM Latest Developments
11.11 SIMILASAN
11.11.1 SIMILASAN Company Information
11.11.2 SIMILASAN Ophthalmic Anti-infective Drug Product Offered
11.11.3 SIMILASAN Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SIMILASAN Main Business Overview
11.11.5 SIMILASAN Latest Developments
11.12 Jianfeng Group
11.12.1 Jianfeng Group Company Information
11.12.2 Jianfeng Group Ophthalmic Anti-infective Drug Product Offered
11.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Jianfeng Group Main Business Overview
11.12.5 Jianfeng Group Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Ophthalmic Anti-infective Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Eyedrops
Table 3. Major Players of Gels
Table 4. Major Players of Ointments
Table 5. Major Players of Other
Table 6. Ophthalmic Anti-infective Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Ophthalmic Anti-infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
Table 9. Ophthalmic Anti-infective Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Ophthalmic Anti-infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
Table 12. Global Ophthalmic Anti-infective Drug Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Ophthalmic Anti-infective Drug Revenue Market Share by Player (2020-2022)
Table 14. Ophthalmic Anti-infective Drug Key Players Head office and Products Offered
Table 15. Ophthalmic Anti-infective Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Ophthalmic Anti-infective Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Ophthalmic Anti-infective Drug Market Size Market Share by Regions (2017-2022)
Table 20. Americas Ophthalmic Anti-infective Drug Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Ophthalmic Anti-infective Drug Market Size Market Share by Country (2017-2022)
Table 22. Americas Ophthalmic Anti-infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
Table 24. Americas Ophthalmic Anti-infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
Table 26. APAC Ophthalmic Anti-infective Drug Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Ophthalmic Anti-infective Drug Market Size Market Share by Region (2017-2022)
Table 28. APAC Ophthalmic Anti-infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
Table 30. APAC Ophthalmic Anti-infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
Table 32. Europe Ophthalmic Anti-infective Drug Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Country (2017-2022)
Table 34. Europe Ophthalmic Anti-infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
Table 36. Europe Ophthalmic Anti-infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Ophthalmic Anti-infective Drug Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Ophthalmic Anti-infective Drug
Table 45. Key Market Challenges & Risks of Ophthalmic Anti-infective Drug
Table 46. Key Industry Trends of Ophthalmic Anti-infective Drug
Table 47. Global Ophthalmic Anti-infective Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Ophthalmic Anti-infective Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Ophthalmic Anti-infective Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Ophthalmic Anti-infective Drug Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Ophthalmic Anti-infective Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Ophthalmic Anti-infective Drug Market Size Market Share Forecast by Application (2023-2028)
Table 53. Alcon Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 54. Alcon Ophthalmic Anti-infective Drug Product Offered
Table 55. Alcon Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Alcon Main Business
Table 57. Alcon Latest Developments
Table 58. AbbVie Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 59. AbbVie Ophthalmic Anti-infective Drug Product Offered
Table 60. AbbVie Main Business
Table 61. AbbVie Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. AbbVie Latest Developments
Table 63. Bausch Health Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 64. Bausch Health Ophthalmic Anti-infective Drug Product Offered
Table 65. Bausch Health Main Business
Table 66. Bausch Health Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Bausch Health Latest Developments
Table 68. Santen Pharmaceutical Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 69. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product Offered
Table 70. Santen Pharmaceutical Main Business
Table 71. Santen Pharmaceutical Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Santen Pharmaceutical Latest Developments
Table 73. Lupin Pharmaceuticals Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 74. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
Table 75. Lupin Pharmaceuticals Main Business
Table 76. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Lupin Pharmaceuticals Latest Developments
Table 78. Apotex Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 79. Apotex Ophthalmic Anti-infective Drug Product Offered
Table 80. Apotex Main Business
Table 81. Apotex Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Apotex Latest Developments
Table 83. Akorn Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 84. Akorn Ophthalmic Anti-infective Drug Product Offered
Table 85. Akorn Main Business
Table 86. Akorn Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Akorn Latest Developments
Table 88. Johnson & Johnson Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 89. Johnson & Johnson Ophthalmic Anti-infective Drug Product Offered
Table 90. Johnson & Johnson Main Business
Table 91. Johnson & Johnson Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Johnson & Johnson Latest Developments
Table 93. Thea pharmaceuticals Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 94. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product Offered
Table 95. Thea pharmaceuticals Main Business
Table 96. Thea pharmaceuticals Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Thea pharmaceuticals Latest Developments
Table 98. URSAPHARM Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 99. URSAPHARM Ophthalmic Anti-infective Drug Product Offered
Table 100. URSAPHARM Main Business
Table 101. URSAPHARM Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. URSAPHARM Latest Developments
Table 103. SIMILASAN Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 104. SIMILASAN Ophthalmic Anti-infective Drug Product Offered
Table 105. SIMILASAN Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. SIMILASAN Main Business
Table 107. SIMILASAN Latest Developments
Table 108. Jianfeng Group Details, Company Type, Ophthalmic Anti-infective Drug Area Served and Its Competitors
Table 109. Jianfeng Group Ophthalmic Anti-infective Drug Product Offered
Table 110. Jianfeng Group Main Business
Table 111. Jianfeng Group Ophthalmic Anti-infective Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Jianfeng Group Latest Developments
List of Figures
List of Figures
Figure 1. Ophthalmic Anti-infective Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Ophthalmic Anti-infective Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Ophthalmic Anti-infective Drug Market Size Market Share by Type in 2021
Figure 7. Ophthalmic Anti-infective Drug in Hospital
Figure 8. Global Ophthalmic Anti-infective Drug Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Ophthalmic Anti-infective Drug in Retail Pharmacy
Figure 10. Global Ophthalmic Anti-infective Drug Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Ophthalmic Anti-infective Drug in Others
Figure 12. Global Ophthalmic Anti-infective Drug Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Ophthalmic Anti-infective Drug Market Size Market Share by Application in 2021
Figure 14. Global Ophthalmic Anti-infective Drug Revenue Market Share by Player in 2021
Figure 15. Global Ophthalmic Anti-infective Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Ophthalmic Anti-infective Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC Ophthalmic Anti-infective Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe Ophthalmic Anti-infective Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Ophthalmic Anti-infective Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas Ophthalmic Anti-infective Drug Value Market Share by Country in 2021
Figure 21. Americas Ophthalmic Anti-infective Drug Consumption Market Share by Type in 2021
Figure 22. Americas Ophthalmic Anti-infective Drug Market Size Market Share by Application in 2021
Figure 23. United States Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Ophthalmic Anti-infective Drug Market Size Market Share by Region in 2021
Figure 28. APAC Ophthalmic Anti-infective Drug Market Size Market Share by Application in 2021
Figure 29. China Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Country in 2021
Figure 36. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Type in 2021
Figure 37. Europe Ophthalmic Anti-infective Drug Market Size Market Share by Application in 2021
Figure 38. Germany Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Ophthalmic Anti-infective Drug Market Size Market Share by Application in 2021
Figure 46. Egypt Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Ophthalmic Anti-infective Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 59. China Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 63. India Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 66. France Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Ophthalmic Anti-infective Drug Market Size 2023-2028 ($ Millions)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)